An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Interim phase 3 results showed the IL-13 monoclonal antibody improves histology and symptoms in EoE, even in participants ...

The first rollout of the vaccine will be in Bayelsa and Kebbi, two states with high seasonal transmission of malaria.

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have ...

GSK plc GSK announced that the FDA has accepted its new drug application (NDA) seeking approval for its investigational, ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...

A decision to relocate a town's library has been upheld despite a consultation into the plans being labelled unfair and not ...

根据最新报道，赛诺菲正在与CD&R进行深入谈判，计划出售Opella ...

▎药明康德内容团队编辑GSK今天宣布，美国FDA已接受其潜在"first-in-class"口服抗生素gepotidacin的新药申请（NDA），用于治疗患有单纯性尿路感染（uUTI，也称为急性膀胱炎）成年或青少年（≥12岁）女性患者，患者体重须≥4 ...

Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...